AbbVie (ABBV) Is One Of The Major Stock To Buy According To Wall Street

As CBS News reported connected April 7, AbbVie Inc. (NYSE:ABBV) and Roche, done their Genentech Unit, person joined TrumpRx. TrumpRx is simply a government-run level that sells medicines straight to consumers astatine discounted prices. With this move, they go the 10th and 11th cause makers connected the platform. AbbVie Inc. (NYSE:ABBV) volition supply its arthritis cause Humira astatine an 86% discount nether a pricing statement with the U.S. government. Genentech has besides agreed to merchantability its flu cause Xofluza for $50, importantly little than its accustomed terms of $168. The full fig of medicines disposable connected TrumpRx has accrued to 61, up from astir 40 erstwhile the level launched earlier this year.

According to CNN’s compilation, AbbVie Inc. (NYSE:ABBV) is presently covered by 33 Wall Street analysts and has a statement Buy rating. Analyst estimates suggest the banal could emergence arsenic precocious arsenic $328, implying much than 58% upside from existent levels.

AbbVie Inc. (NYSE:ABBV) operates arsenic a biopharmaceutical company. It is progressive successful the development, commercialization, manufacturing, and merchantability of medicines and therapies. The institution provides Skyrizi, Rinvoq, Imbruvica, Elahere, Venclexta, Epkinly, and Emrelis.

While we admit the imaginable of ABBV arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 10 Companies That Partnered With Nvidia successful 2026 and  10 Stocks That Will Skyrocket When Oil Prices Fall.

Disclosure: None. Follow Insider Monkey connected Google News.